S F Ye 1 , Z Liu 1 , Y F Wang 1 , P He 1 , L J Wen 1 , B Teng 1 . Show Affiliations »
Abstract
Objective:To systemically review the therapeutic effect of probitics on allergic rhinitis(AR).Method:Literatures about the effect of probitics on AR were searched in PubMed. The Cochrane Library, Web of Science and CNKI, WanFang Data and VIP inception to April 2016,and 2 reviewers independently screened literatures according to the inclusion and exclusion criteria, extracted data, and assessed the risk of bias of included studies. Then meta-analysis was performed using RevMan5.2 software. Result:A total of 16RCTs involving1374 patients were included in the meta-analysis, including 809 cases in the probitic group and 568 cases in the placebo group. The results of meta-analysis showed that the efficacy of probitic group was superior to the placebo group in total RQLQ,nasal RQLQ,eye RQLQ and the serum eosinophil count,the difference was statistically significant [MD=-4.43,95%CI(-8.65~-0.20);MD=-1.08,95%CI(-1.89~0.27);MD=-0.95,95%CI(-1.46~-1.44);MD=-28.40,95%CI(-43.53~-13.26)].There was no significant difference in Serum IgE between the probitic group and the placebo group(P>0.05).There was no significant difference in the NTSS value between the lactobacillus group and the bifidobacterium group(P>0.05). Conclusion: Compared to the placebo, probitics can effectively reduce symptom scores of patients with AR;and different strains of probitics indicated no significant differences in improving nasal symptoms. Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.
Objective:To systemically review the therapeutic effect of probitics on allergic rhinitis (AR).Method:Literatures about the effect of probitics on AR were searched in PubMed. The Cochrane Library, Web of Science and CNKI, WanFang Data and VIP inception to April 2016,and 2 reviewers independently screened literatures according to the inclusion and exclusion criteria, extracted data, and assessed the risk of bias of included studies. Then meta-analysis was performed using RevMan5.2 software. Result:A total of 16RCTs involving1374 patients were included in the meta-analysis, including 809 cases in the probitic group and 568 cases in the placebo group. The results of meta-analysis showed that the efficacy of probitic group was superior to the placebo group in total RQLQ,nasal RQLQ,eye RQLQ and the serum eosinophil count,the difference was statistically significant [MD=-4.43,95%CI(-8.65~-0.20);MD=-1.08,95%CI(-1.89~0.27);MD=-0.95,95%CI(-1.46~-1.44);MD=-28.40,95%CI(-43.53~-13.26)].There was no significant difference in Serum IgE between the probitic group and the placebo group(P>0.05).There was no significant difference in the NTSS value between the lactobacillus group and the bifidobacterium group(P>0.05). Conclusion: Compared to the placebo, probitics can effectively reduce symptom scores of patients with AR;and different strains of probitics indicated no significant differences in improving nasal symptoms. Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.
Entities: Disease
Gene
Species
Keywords:
Meta analysis; allergic rhinitis; probitic; treatment
Mesh: See more »
Year: 2017
PMID: 29871288 DOI: 10.13201/j.issn.1001-1781.2017.06.014
Source DB: PubMed Journal: Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi ISSN: 2096-7993